Antithrombin determinants of coronary artery disease in transplanted human hearts.
Labarrere
C A
CA
Division of Experimental Pathology, Methodist Hospital, Indianapolis, IN 46202, USA.
Faulk
W P
WP
D000990:Antithrombin III / Q000502:physiology*; D020152:Antithrombin III Deficiency; D002196:Capillaries / Q000378:metabolism / Q000473:pathology; D003327:Coronary Disease / Q000097:blood* / Q000209:etiology; D003331:Coronary Vessels / Q000378:metabolism / Q000473:pathology; D004699:Endocardium / Q000473:pathology; D016228:Endothelial Growth Factors / Q000096:biosynthesis; D005337:Fibrin / Q000032:analysis; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008222:Lymphokines / Q000096:biosynthesis; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D011379:Prognosis; D010959:Tissue Plasminogen Activator / Q000032:analysis; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000990:Antithrombin III; D005337:Fibrin; D010959:Tissue Plasminogen Activator